Milk Volume Outcomes Following Oral Nicotinamide Riboside Supplementation in Mothers of Extremely Preterm Infants

ConditionsPreterm Birth Inadequate Milk Production

Trial statusNot yet recruiting

Trial phasePhase 2, Phase 3

Trial typeInterventional

Biological sexFemale

Age18+

SponsorUniversity of California, Davis

About this trial

This study aims to evaluate the feasibility and effects of nicotinamide riboside (NR) supplementation in lactating mothers of infants expected to be hospitalized in the neonatal intensive care unit (NICU) for at least four weeks.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Nicotinamide Riboside (NR)
Placebo

Treatment groups

40 Participants

are divided into 2 treatment groups

Sponsors and collaborators

University of California, Davis

Lead sponsor

ChromaDex, Inc.

Collaborator

Source ClinicalTrials.gov